Whitehawk Therapeutics, Inc. (WHWK) Stock Profile — Insider Trades & Financials

Revenue$0

Net Income-$23.3M

EPS$0.04

Market Cap$160.0M

Price Performance

Historical data including institutional events

Loading price data...

Company Profile

David Lennon

CEO & Executive Director

Whitehawk Therapeutics, Inc., a clinical-stage oncology therapeutics company that develops technologies to establish tumor biology for cancer treatments. It provides three next generation antibody drug conjugates (ADC) portfolio to treat cancer. The company was formerly known as Aadi Bioscience, Inc. and changed its name to Whitehawk Therapeutics, Inc. in August 2021. Whitehawk Therapeutics, Inc. was incorporated in 2007 and is headquartered in Morristown, New Jersey.

Founded: 2007
Employees: 23
Headquarters: Morristown, New Jersey, United States
Website

⚡

Core Efficiency

ROE?

-17.06%

ROA?

-15.42%

D/E Ratio?

0.11

📊

Profitability Ratios

Current Ratio?

10.26

Loading comparison...

Earnings Calendar

Filing history and next expected filing date

Next Expected Filing

Aug 27, 2026 (in 140 days)

Annual Report (10-K) — Based on filing pattern

Aug 27, 2026

Predicted10-K

Mar 12, 2026

10-KQ4 20253d after period end

Mar 12, 2026

10-KFY 202571d after period end

Nov 6, 2025

10-QQ3 20252d after period end

Aug 7, 2025

10-QQ2 20253d after period end

May 8, 2025

10-QQ1 20256d after period end

Mar 28, 2025

10-KQ4 20244d after period end

Mar 28, 2025

10-KFY 202587d after period end

Nov 6, 2024

10-QQ3 20245d after period end

Loading company sections...

Whitehawk Therapeutics, Inc.

Price Performance

Company Profile

Core Efficiency

Profitability Ratios

Earnings Calendar

Core Efficiency

Profitability Ratios

Earnings Calendar

Data Freshness